window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Biotech,CDMOs & Manufacturing,Drug Development,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Onyx Scientific expands material science capabilities as part of 25th anniversary milestone

    Onyx Scientific has expanded its solid form and material science [...]

    January 19, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    From awareness to action: Linus Health drives next era of early brain health detection

    Linus Health is accelerating its efforts in early brain health [...]

    January 19, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    MGS launches A.i.r. platform delivering customizable auto-injector solutions

    MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

    January 19, 2026
  • Digital Health,Market Access & Commercialization,Medical devices,Research & Development,Technology and platforms

    Profusa launches Lumee tissue oxygen research offering to generate first commercial revenue

    Profusa has launched a research-use-only version of its Lumee tissue [...]

    January 19, 2026
  • Data Management,Genomics and sequencing,Research & Development,Technology and platforms

    SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform

    SPT Labtech has announced the availability of validated automated workflows [...]

    January 15, 2026
  • Biomanufacturing,Drug Development,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    Thermo Fisher launches DXR3 SmartRaman+ for at-line pharmaceutical and industrial testing

    Thermo Fisher Scientific has launched the DXR3 SmartRaman+ Raman Spectrometer [...]

    January 14, 2026
  • European biotech,Partnerships & Funding,Research & Development,Technology and platforms

    Novo Nordisk Foundation commits DKK 5.5BN (EUR 736M) to BioInnovation Institute expansion

    The Novo Nordisk Foundation has committed up to DKK 5.5 [...]

    January 14, 2026
  • Artificial Intelligence,Biotech,Drug Development,Mergers & Acquisitions,Technology and platforms

    CombinAbleAI to be acquired by insitro to expand AI drug discovery platform

    AI therapeutics company, insitro, has agreed to acquire CombinAbleAI in [...]

    January 14, 2026
  • Artificial Intelligence,Data Management,Pharmaceuticals and therapeutics,Technology and platforms

    Gap emerges between agentic AI ambition and real-world use in pharma, report finds

    A growing gap has emerged between how life sciences and [...]

    January 13, 2026
  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top